DS
HRMY icon

David Shaw’s Harmony Biosciences HRMY Stock Holding History

David Shaw’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.93M Sell
52,879
-48,548
-48% -$1.53M ﹤0.01% 3238
2026
Q1 		$2.84M Sell
101,427
-12,883
-11% -$422K ﹤0.01% 2637
2025
Q4 		$4.28M Sell
114,310
-78,317
-41% -$2.58M ﹤0.01% 2440
2025
Q3 		$5.31M Sell
192,627
-60,354
-24% -$2.08M ﹤0.01% 2165
2025
Q2 		$7.99M Sell
252,981
-66,723
-21% -$2.15M 0.01% 1671
2025
Q1 		$10.6M Sell
319,704
-160,901
-33% -$5.77M 0.01% 1342
2024
Q4 		$16.5M Buy
480,605
+124,656
+35% +$4.28M 0.01% 1154
2024
Q3 		$14.2M Buy
355,949
+45,945
+15% +$1.61M 0.01% 1203
2024
Q2 		$9.35M Buy
310,004
+30,569
+11% +$919K 0.01% 1378
2024
Q1 		$9.38M Sell
279,435
-2,321
-0.8% -$74.5K 0.01% 1405
2023
Q4 		$9.1M Buy
281,756
+13,943
+5% +$389K 0.01% 1433
2023
Q3 		$8.78M Buy
267,813
+27,352
+11% +$950K 0.01% 1377
2023
Q2 		$8.46M Buy
240,461
+45,975
+24% +$1.59M 0.01% 1478
2023
Q1 		$6.35M Sell
194,486
-29,485
-13% -$1.34M 0.01% 1746
2022
Q4 		$12.3M Buy
223,971
+177,772
+385% +$9.77M 0.01% 1262
2022
Q3 		$2.05M Buy
46,199
+9,423
+26% +$460K ﹤0.01% 2985
2022
Q2 		$1.79M Buy
36,776
+8,317
+29% +$374K ﹤0.01% 3163
2022
Q1 		$1.39M Buy
+28,459
New +$1.16M ﹤0.01% 3638
2021
Q3 		– Sell
-44,765
Closed -$1.26M – 5067
2021
Q2 		$1.26M Buy
+44,765
New +$1.34M ﹤0.01% 3354

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

David Shaw's HRMY Position: Q2 2026 in Review

David Shaw reduced its Harmony Biosciences (HRMY) stake by 48% in Q2 2026, selling an estimated $1.53M and leaving 52,879 shares worth $1.93M. The position accounts for ﹤0.01% of the portfolio, ranked #3238.

David Shaw first reported a position in HRMY in Q2 2021 and has held it in 19 quarters since. The position peaked at $16.5M in Q4 2024. 325 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • David Shaw held 52,879 shares of Harmony Biosciences worth $1.93M as of Q2 2026.
  • David Shaw sold 48,548 Harmony Biosciences shares in Q2 2026, an estimated $1.53M.
  • Harmony Biosciences made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3238 holding.
  • David Shaw first reported a position in Harmony Biosciences in Q2 2021 and has held it in 19 quarters since.
  • David Shaw's Harmony Biosciences position peaked at $16.5M in Q4 2024.
  • 325 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.